Cells, scaffolds and bioreactors for tissue-engineered heart valves: A journey from basic concepts to contemporary developmental innovations

European Journal of Cardio-thoracic Surgery

Volumn 39, Issue 4, 2011, Pages 523-531

  Gandaglia, Alessandro ^a   Bagno, Andrea ^a   Naso, Filippo ^a   Spina, Michele ^a   Gerosa, Gino ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Bioreactors; Dynamic conditioning; Heart valves; Tissue engineering

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CALCITRIOL; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; HEPATOMA DERIVED GROWTH FACTOR; INSULIN; PLATELET DERIVED GROWTH FACTOR BB; RETINOIC ACID; SCATTER FACTOR; SOMATOMEDIN C; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ALLOGRAFT; BIOPROSTHESIS; BIOREACTOR; BIOREACTOR DESIGN; BODY GROWTH; BONE REMODELING; CALCIFICATION; CALCIUM MOBILIZATION; CELL DIFFERENTIATION; CELL FUNCTION; CELLULAR DISTRIBUTION; CHILD GROWTH; COLONY FORMATION; GENE EXPRESSION; HEART VALVE; HEART VALVE PROSTHESIS; HEMODYNAMICS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROSTHESIS FAILURE; REVIEW; SOMATIC CELL; STEM CELL; TISSUE ENGINEERED HEART VALVE; TISSUE ENGINEERING; TISSUE GROWTH; TISSUE REGENERATION; TISSUE REPAIR; VALVULAR HEART DISEASE; XENOGRAFT;

BIOPROSTHESIS; BIOREACTORS; HEART VALVE PROSTHESIS; HEART VALVES; HUMANS; PROSTHESIS DESIGN; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 79952537450     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.07.030     Document Type: Review

References (120)

1. Della Rocca F., Sartore S., Guidolin D., Bertipaglia B., Gerosa G., Casarotto D., Pauletto P. Cell composition of the human pulmonary valve: a comparative study with the aortic valve - the VESALIO project. Vitalitate Exornatum Succedaneum Aorticum Labore Ingegnoso Obtinebitur. Ann Thorac Surg 2000, 70:1594-1600.
2. Bertipaglia B., Ortolani F., Petrelli L., Gerosa G., Spina M., Pauletto P., Casarotto D., Marchini M., Sartore S. Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: the VESALIO project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur). Ann Thorac Surg 2003, 75:1274-1282.
3. Spina M., Ortolani F., El Messlemani A., Gandaglia A., Bujan J., Garcia-Honduvilla N., Vesely I., Gerosa G., Casarotto D., Petrelli L., Marchini M. Isolation of intact aortic valve scaffolds for heart-valve bioprostheses: extracellular matrix structure, prevention from calcification, and cell repopulation features. J Biomed Mater Res A 2003, 67:1338-1350.
4. Taylor P.M. Biological matrices and bionanotechnology. Philos Trans R Soc Lond B Biol Sci 2007, 362:1313-1320.
5. Samouillan V., Dandurand J., Lacabanne C., Thoma R.J., Adams A., Moore M. Comparison of chemical treatments on the chain dynamics and thermal stability of bovine pericardium collagen. J Biomed Mater Res A 2003, 64:330-338.
6. Van Nooten G., Somers P., Cornelissen M., Bouchez S., Gasthuys F., Cox E., Sparks L., Narine K. A cellular porcine and kangaroo aortic valve scaffolds show more intense immune-mediated calcification than cross-linked Toronto SPV valves in the sheep model. Interact Cardiovasc Thorac Surg 2006, 5:544-549.
7. Berrier A.L., Yamada K.M. Cell-matrix adhesion. J Cell Physiol 2007, 213:565-573.
8. Zund G., Breuer C.K., Shinoka T., Ma P.X., Langer R., Mayer J.E., Vacanti J.P. The in vitro construction of a tissue engineered bioprosthetic heart valve. Eur J Cardiothorac Surg 1997, 11:493-497.
9. Wilson G.J., Courtman D.W., Klement P., Lee J.M., Yeger H. Acellular matrix: a biomaterials approach for coronary artery bypass and heart valve replacement. Ann Thorac Surg 1995, 60:353-358.
10. Hecker L., et Birla R.K. Engineering the heart piece by piece: state of the art in cardiac tissue engineering. Regenerative Med 2007, 2:125-144.
11. Shachar M., et Cohen S. Cardiac tissue engineering, ex-vivo: design principles in biomaterials and bioreactors. Heart Fail Rev 2003, 8:271-276.
12. Colton C.K. Implantable biohybrid artificial organs. Cell Transplant 1995, 4:415-436.
13. Knight R.L., Booth C., Wilcox H.E., Fisher J., Ingham E. Tissue engineering of cardiac valves: re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells. J Heart Valve Dis 2005, 14:806-813.
14. Hoerstrup S.P., Kadner A., Melnitchouk S., Trojan A., Eid K., Tracy J., Sodian R., Visjager J.F., Kolb S.A., Grunenfelder J., Zund G., Turina M.I. Tissue engineering of functional trileaflet heart valve from human marrow stromal cells. Circulation 2002, 106:143-150.
15. Cebotari S., Lichtenberg A., Tudorache I., Hilfiker A., Mertsching H., Leyh R., Breymann T., Kallenbach K., Maniuc L., Batrinac A., Repin O., Maliga O., Ciubotaru A., Haverich A. Clinical application of tissue engineered human heart valve using autologous progenitor cells. Circulation 2006, 114:132-137.
16. Schmidt D., Mol A., Breymann C., Achermann J., Odermatt B., Gössi M., Neuenschwander S., Prêtre R., Genoni M., Zund G., Hoerstrup S. Living autologous heart valves engineered from human prenatally harvested progenitors. Circulation 2006, 114:125-131.
17. Schmidt D., Hoerstrup S.P. Tissue engineered heart valves based on human cells. Swiss Med Wkly 2006, 136:618-623.
18. Schmidt D., Mol A., Neuenschwander S., Breymann C., Gössi M., Zund G., Turina M., Hoerstrup S.P. Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells. Eur J Cardiothorac Surg 2005, 27:795-800.
19. Sodian R., Lueders C., Kraemer L., Kuebler W., Shakibaei M., Reichart B., Daebritz S., Hetzer R. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells. Ann Thorac Surg 2006, 81:2207-2216.
20. Hoerstrup S.P., Sodian R., Daebritz S., Wang J., Bacha E.A., Martin D.P., Moran A.M., Guleserian K.J., Sperling J.S., Kaushal S., Vacanti J.P., Schoen F.J., Mayer J.E. Functional living trileaflet heart valves grown in vitro. Circulation 2000, 102:44-49.
21. Zeltinger J., Landeen L.K., Alexander H.G., Kidd I.D., Sibanda B. Development and characterization of tissue-engineered aortic valves. Tissue Eng 2001, 7:9-22.
22. Lueders C., Sodian R., Shakibaei M., Hetzer R. Short-term culture of human neonatal myofibroblasts seeded using a novel three-dimensional rotary seeding device. ASAIO J 2006, 52:310-314.
23. Mol A., Rutten M.C.M., Driessen N.J.B., Bouten C.V.C., Zund G., Baaijens F.P.T., Hoerstrup S.P. Autologous human tissue-engineered heart valves: prospects for systemic application. Circulation 2006, 114:152-158.
24. Sodian R., Hoerstrup S.P., Sperling J.S., Daebritz S.H., Martin D.P., Schoen F.J., Vacanti J.P., Mayer J.E. Tissue engineering of heart valves: in vitro experience. Ann Thorac Surg 2000, 70:140-144.
25. Schenke-Layland K., Opitz F., Gross M., Döring C., Halbhuber K.J., Schirrmeister F., Wahlers Th, Stock U.A. Complete dynamic repopulation of decellularized heart valves by application of defined physical signals-an in vitro study. Cardiovasc Res 2003, 60:497-509.
26. Lichenberg A., Cebotari S., Tudorache I., Sturz I., Winterhalter M., Hilfiker A., Haverich A. Flow-dependent re-endothelialization of tissue-engineered heart valves. J Heart Valve Dis 2006, 15:287-293.
27. Lichtenberg A., Tudorache I., Cebotari S., Ringes-Lichtenberg S., Sturz G., Hoeffler K., Hurschler C., Brandes G., Hilfiker A., Haverich A. In vitro re-endothelialization of detergent decellularized heart valves under simulated physiological dynamic conditions. Biomaterials 2006, 27:4221-4229.
28. Breymann C., Schmidt D., Hoerstrup S.P. Umbilical cord cells as a source of cardiovascular tissue engineering. Stem Cell Rev 2006, 2:87-92.
29. McBrearty B.A., Clark L.D., Zhang X.M., Blankenhorn E.P., Heber-Katz E. Genetic analysis of a mammalian wound-healing trait. Proc Natl Acad Sci U S A 1998, 95:11792-11797.
30. Mendelson K., Schoen F.J. Heart valve tissue engineering: concepts, approaches, progress and challenges. Ann Biomed Eng 2006, 34(12):1799-1819.
31. Appleton A.J., Appleton C.T., Boughner D.R., Rogers K.A. Vascular smooth muscle cells as a valvular interstitial cell surrogate in heart valve tissue engineering. Tissue Eng Part A 2009, 15(12):3889-3897.
32. Hoerstrup S.P., Zünd G., Lachat M., Schoeberlein A., Uhlschmid G., Vogt P., Turina M. Tissue engineering: a new approach in cardiovascular surgery; seeding of human fibroblasts on resorbable mesh. Swiss Surg 1998, (Suppl 2):23-25.
33. Rothenburger M., Vischer P., Völker W., Glasmacher B., Berendes E., Scheld H.H., Deiwick M. In vitro modelling of tissue using isolated vascular cells on a synthetic collagen matrix as a substitute for heart valves. Thorac Cardiovasc Surg 2001, 49:204-209.
34. Wilcox H.E., Korossis S.A., Booth C., Watterson K.G., Kearney J.N., Fisher J., Ingham E. Biocompatibility and recellularization potential of an acellular porcine heart valve matrix. J Heart Valve Dis 2005, 14:228-236.
35. Breuer C.K., Mettler B.A., Anthony T., Sales V.L., Schoen F.J., Mayer J.E. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute. Tissue Eng 2004, 10:1725-1736.
36. Vincentelli A., Wautot F., Juthier F., Fouquet O., Corseaux D., Marechaux S., Le Tourneau T., Fabre O., Susen S., Van Belle E., Mouquet F., Decoene C., Prat A., Jude B. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates?. J Thorac Cardiovasc Surg 2007, 134:424-432.
37. Sakiyama-Elbert S.E., Panitch A., Hubbell J.A. Development of growth factor fusion proteins for cell-triggered drug delivery. FASEB J 2001, 15:1300-1302.
38. Zisch A.H., Schenk U., Schense J.C., Sakiyama-Elbert S.E., Hubbell J.A. Covalently conjugated VEGF - fibrin matrices for endothelialization. J Control Release 2001, 72:101-113.
39. Hashimoto G., EInoki I., Shiomi Tnomoto H., Nakamura H., Makino K., Ikeda E., Takata S., Kobayashi K., Okada Y. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J 2002, 16:219-221.
40. Takeyoshi O., Yoshiki S., Shigemitsu I., Takashi K., Yuichiro U., Chris C., Hikaru M., Yutaka O. Fibronectin-hepatocyte growth factor enhances reendothelialization in tissue encineered heart valve. Ann Thorac Surg 2005, 80:1794-1802.
41. Sabine C.W., Gabriele S., Hans-Peter R., Teut R., Bernhard R.B. Influence of growth factors on the proliferation of vascular smooth muscle cells isolated from subtotally nephrectomised rats after endothelin or angiotensin II antagonism. Nephrol Dial Transplant 2005, 20:312-318.
42. Miano J.M., Vlasic N., Tota R., Stemerman M.B. Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury. A putative in vivo mechanism for autocrine growth. Arterioscler Thromb 1993, 13:211-219.
43. Wen-Hua F., Michael P., Morris J.K. Connective tissue growth factor (CTGF) stimulates vascular smooth muscle cell growth and migration in vitro. Eur J Cell Biol 2000, 79:915-923.
44. Everett A.D., Lobe D.R., Matsumura M.E., Nakamura H., McNamara C.A. Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development. J Clin Invest 2000, 105:567-575.
45. Long J.L., Tranquillo R.T. Elastic fiber production in cardiovascular tissue-equivalents. Matrix Biol 2003, 22:339-350.
46. Tukaj C., Kubasik-Juraniec J., Kraszpulsky M. Morphological changes of aortal smooth muscle cells exposed to calcitriol in culture. Med Sci Monit 2000, 6:668-674.
47. Hayashi A., Suzuky T., Tajima S. Modulation of elastin expression and cell proliferation by retinoids in cultured vascular smooth muscle cells. J Biochem 1995, 117:132-136.
48. Tajima S., Hayashi A., Suzuky T. Elastin expression is upregulated by retinoic acid but not by retinol in chick embryonic skin fibroblast. J Dermatol Sci 1997, 15:166-172.
49. Huang S.D., Liu X.H., Bai C.G., Lu F.L., Yuan Y., Gong D.J., Xu Z.Y. Synergistic effect of fibronectin and hepatocyte growth factor on stable cell-matrix adhesion, re-endothelialization, and reconstitution in developing tissue-engineered heart valves. Heart Vessels 2007, 22:116-122.
50. Shi Y., Tu Z., Wang W., Li Q., Ye F., Wang J., Qiu J., Zhang L., Bu H., Li Y. Homologous peptide of connective tissue growth factor ameliorates epithelial to mesenchymal transition of tubular epithelial cells. Cytokine 2006, 36:35-44.
51. Carrier R.L., Papadaki M., Rupnick M., Schoen F.J., Bursac N., Langer R., Freed L.E., Vunjak-Novakovic G. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng 1999, 64:580-589.
52. Fontova A., Soley A., Galvez J., Sarro E., Lecina M., Rosell J., Riu P., Cairo J., Godia F., Bragos R. Multiple automated minibioreactor system for multifunctional screening in biotechnology. Conf Proc IEEE Eng Med Biol Soc 2006, 1:632-635.
53. Ruel J., Lachance G. A new bioreactor for the development of tissue-engineered heart valves. Ann Biomed Eng 2009, 37:674-681.
54. Eibl R., Kaiser S., Lombriser R., Eibl D. Disposable bioreactor: the current state-of-the-art and recommended applications in biotechnology. Appl Microbiol Biotechnol 2010, 86:41-49.
55. Rao G., Moreira A., Brorson K. Disposable bioprocessing: the future has arrived. Biotechnol Bioeng 2009, 102:348-356.
56. Ohshima N., Yanagi K., Miyoshi H. Packed-bed type reactor to attain high density culture of hepatocytes for use as a bioartificial liver. Artif Organs 1997, 21:1169-1176.
57. Hoehn A., Klaus D.M., Stodieck L.S. A modular suite of hardware enabling spaceflight cell culture research. J Gravit Physiol 2004, 11:39-49.
58. Seliktar D., Black R.A., Vito R.P., Nerem R.M. Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann Biomed Eng 2000, 28:351-362.
59. Vesely I. Heart valve tissue engineering. Circ Res 2005, 97:743-755.
60. Neidert M.R., Tranquillo R.T. Tissue-engineered valves with commissural alignment. Tissue Eng 2006, 12:891-903.
61. Kitamura T., Affeld K., Mohnhaupt A. Design of a new pulse duplicator system for prosthetic heart valves. J Biomech Eng 1987, 109:43-47.
62. Reul H., Potthast K. Durability/wear testing of heart valve substitutes. J Heart Valve Dis 1998, 7:151-157.
63. Schichl K., Affeld K. A computer controlled versatile pulse duplicator for precision testing of artificial heart valves. Int J Artif Organs 1993, 16:722-728.
64. Dumont K., Yperman J., Verbeken E., Segers P., Meuris B., Vandenberghe S., Flameng W., Verdonck P.R. Design of a new pulsatile bioreactor for tissue engineered aortic heart valve formation. Artif Organs 2002, 26:710-714.
65. Seliktar D., Nerem R.M., Galis Z.S. Mechanical strain-stimulated remodeling of tissue-engineered blood vessel constructs. Tissue Eng 2003, 9:657-666.
66. Solan A., Mitchell S., Moses M., Niklason L. Effect of pulse rate on collagen deposition in the tissue-engineered blood vessel. Tissue Eng 2003, 9:579-586.
67. Dvir T., Benishti N., Shachar M., Cohen S. A novel perfusion bioreactor providing a homogenous milieu for tissue regeneration. Tissue Eng 2006, 12:2843-2852.
68. Hildebrand D.K., Wu Z.J., Mayer J.E., Sacks M.S. Design and hydrodynamic evaluation of a novel pulsatile bioreactor for biologically active heart valves. Ann Biomed Eng 2004, 32:1039-1049.
69. Engelmayr G.C., Hildebrand D.K., Sutherland F.W., Mayer J.E., Sacks M.S. A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials. Biomaterials 2003, 24:2523-2532.
70. Mol A., Driessen N.J., Rutten M.C., Hoerstrup S.P., Bouten C.V., Baaijens F.P. Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning approach. Ann Biomed Eng 2005, 33:1778-1788.
71. Karim N., Golz K., Bader A. The cardiovascular tissue-reactor: a novel device for the engineering of heart valves. Artif Organs 2006, 30:809-814.
72. Flanagan T.C., Cornelissen C., Koch S., Tschoeke B., Sachweh J.S., Schmitz-Rode T., Jockenhoevel S. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Biomaterials 2007, 28:3388-3397.
73. Morsi Y.S., Yang W.W., Owida A., Wong C.S. Development of a novel pulsatile bioreactor for tissue culture. J Artif Organs 2007, 10:109-114.
74. Williams C., Wick T.M. Perfusion bioreactor for small diameter tissue engineered arteries. Tissue Eng 2004, 10(5-6):930-941.
75. Barron V., Lyons E., Stenson-Cox C., McHugh P.E., Pandit A. Bioreactors for cardiovascular cell and tissue growth: a review. Ann Biomed Eng 2003, 31:1017-1030.
76. Shinoka T., Breuer C.K., Tanel R.E., Zund G., Miura T., Ma P.X., Langer R., Vacanti J.P., Mayer J.E. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg 1995, 60:513-516.
77. Lichtenberg A., Tudorache I., Cebotari S., Suprunov M., Tudorache G., Goerler H., Park J.K., Hilfiker-Kleiner D., Ringes-Lichtenberg S., Karck M., Brandes G., Hilfiker A., Haverich A. Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions. Circulation 2006, 114:559-565.
78. Dohmen P.M., Lembcke A., Holinski S., Kivelitz D., Braun J.P., Pruss A., Konertz W. Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure. Ann Thorac Surg 2007, 84:729-736.
79. Lee D.J., Steen J., Jordan J.E., Kincaid E.H., Kon N.D., Atala A., Berry J., Yoo J.J. Endothelialization of heart valve matrix using a computer-assisted pulsatile bioreactor. Tissue Eng Part A 2009, 15:807-814.
80. Rosso F., Marino G., Giordano A., Barbarisi M., Parmeggiani D., Barbarisi A. Smart materials as scaffolds for tissue engineering. J Cell Physiol 2005, 203:465-470.
81. Jockenhoevel S., Zund G., Hoerstrup S., Schnell A., Turina M. Cardiovascular tissue engineering: a new laminar flow chamber for in vivo improvement of mechanical tissue properties. ASAIO J 2002, 48:8-11.
82. Engelmayr G.C., Rabkin E., Sutherland F.W., Schoen F.J., Mayer J.E., Sacks M.S. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Biomaterials 2005, 26:175-187.
83. Engelmayr G.C., Sales V.L., Mayer J.E., Sacks M.S. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: implications for engineered heart valve tissues. Biomaterials 2006, 27:6083-6095.
84. Grayson W.L., Zhao F., Izadpanah R., Bunnell B., Ma T. Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. J Cell Physiol 2006, 207:331-339.
85. Grayson W.L., Zhao F., Bunnell B., Ma T. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun 2007, 358:948-953.
86. Gronthos S., Simmons P.J., Graves S.E., Robey P.G. Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone 2001, 28:174-181.
87. Butcher J.T., Nerem R.M. Valvular endothelial cells and the mechanoregulation of valvular pathology. Philos Trans R Soc Lond B Biol Sci 2007, 362:1445-1457.
88. Balachandran K., Konduri S., Sucosky P., Jo H., Yoganathan A.P. An ex vivo study of the biological properties of porcine aortic valves in response to circumferential cyclic stretch. Ann Biomed Eng 2006, 34:1655-1665.
89. Tolstrup K., Roldan C.A., Qualls C.R., Crawford M.H. Aortic valve sclerosis, mitral annular calcium, and aortic root sclerosis as markers of atherosclerosis in men. Am J Cardiol 2002, 89:1030-1034.
90. Pate G.E. Association between aortic stenosis and hypertension. J Heart Valve Dis 2002, 11:612-614.
91. Warnock J.N., Konduri S., He Z., Yoganathan A.P. Design of a sterile organ culture system for the ex vivo study of aortic heart valves. J Biomech Eng 2005, 127:857-861.
92. Stock U.A., Vacanti J.P. Cardiovascular physiology during fetal development and implications for tissue engineering. Tissue Eng 2001, 7:1-7.
93. Alpesh P., Benjamin F., Martin S., Kibret M. Elastin biosynthesis: the missing link in tissue-engineered blood vessels. Cardiovasc Res 2006, 71:40-49.
94. Rodgers U.R., Weiss A.S. Cellular interactions with elastin. Pathol Biol 2005, 53:390-398.
95. Isenberg B.C., Tranquillo R.T. Long-term cyclic distention enhances the mechanical properties of collagen-based media-equivalents. Ann Biomed Eng 2003, 31:937-949.
96. Kim B.S., Mooney D.J. Scaffolds for engineering smooth muscle under cyclic mechanical strain conditions. J Biomech Eng 2000, 122:210-215.
97. Kim B.S., Nilkolovski J., Bonadio J., Mooney D.J. Cyclic mechanical strain regulates the development of engineered smooth muscle tissue. Nat Biotechnol 1999, 17:979-983.
98. Kim B.S., Nilkolovski J., Bonadio J., Smiley E., Mooney D.J. Engineered smooth muscle tissues: regulating cell phenotype with the scaffold. Exp Cell Res 1999, 251:318-328.
99. Opitz F., Schenke-Layland K., Richter W., Martin D.P., Degenkolbe I., Wahlers T.H. Tissue engineering of ovine aortic blood vessel substitutes using applied shear stress and enzimatically derived vascular smooth muscle cells. Ann Biomed Eng 2004, 32:212-222.
100. Migneco F., Hollister S.J., Birla R.K. Tissue-engineered heart valve prostheses: 'state of the heart'. Regen Med 2008, 3:399-419.
101. Vismara R., Soncini M., Talò G., Dainese L., Guarino A., Redaelli A., Fiore G.B. A bioreactor with compliance monitoring for heart valve grafts. Ann Biomed Eng 2010, 38:100-108.
102. Mol A., Bouten C.V., Zünd G., Günter C.I., Visjager J.F., Turina M.I., Baaijens F.P., Hoerstrup S.P. The relevance of large strains in functional tissue engineering of heart valves. Thorac Cardiovasc Surg 2003, 51:78-83.
103. Vilendrer K, Nickel T. Bioreactor with plurality of chambers for conditioning intravascular tissue engineered medical products. US Patent 7348175.
104. Webb A.R., Macrie B.D., Ray A.S., Russo J.E., Siegel A.M., Glucksberg M.R., Ameer G.A. In vitro characterization of a compliant biodegradable scaffold with a novel bioreactor system. Ann Biomed Eng 2007, 35:1357-1367.
105. Huh J., Bakaeen F. Heart valve replacement: which valve for which patient?. Curr Cardiol Rep 2006, 8:109-116.
106. Mertsching H., Hansmann J. Bioreactor technology in cardiovascular tissue engineering. Adv Biochem Eng Biotechnol 2009, 112:29-37.
107. Schenke-Layland K., Riemann I., Damour O., Stock U.A., König K. Two-photon microscopes and in vivo multiphoton tomographs - powerful diagnostic tools for tissue engineering and drug delivery. Adv Drug Deliv Rev 2006 Sep, 58:878-896.
108. Zhou J., Fritze O., Schleicher M., Wendel H.P., Schenke-Layland K., Harasztosi C., Hu S., Stock U.A. Impact of heart valve decellularization on 3-D ultrastructure, immunogenicity and thrombogenicity. Biomaterials 2010, 31:2549-2554.
109. Syedain Z.H., Tranquillo R.T. Controlled cyclic stretch bioreactor for tissue-engineered heart valves. Biomaterials 2009, 30:4078-4084.
110. Boerboom R.A., Rubbens M.P., Driessen N.J., Bouten C.V., Baaijens F.P. Effect of strain magnitude on the tissue properties of engineered cardiovascular constructs. Ann Biomed Eng 2008, 36:244-253.
111. Syedain Z.H., Weinberg J.S., Tranquillo R.T. Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissue. Proc Natl Acad Sci U S A 2008, 105:6537-6542.
112. Robinson P.S., Johnson S.L., Evans M.C., Barocas V.H., Tranquillo R.T. Functional tissue-engineered valves from cell-remodeled fibrin with commissural alignment of cell-produced collagen. Tissue Eng Part A 2008, 14:83-95.
113. Stock U.A., Sakamoto T., Hatsuoka S., Martin D.P., Nagashima M., Moran A.M., Moses M.A., Khalil P.N., Schoen F.J., Vacanti J.P., Mayer J.E. Patch augmentation of the pulmonary artery with bioabsorbable polymers and autologous cell seeding. J Thorac Cardiovasc Surg 2000, 120:1158-1167.
114. Engelmayr G.C., Sacks M.S., Schoen F.J., Mayer J.E. From stem cells to viable autologous semilunar heart valve. Circulation 2005, 111(21):2783-2791.
115. Butler D.L., Goldstein S.A., Guilak F. Functional tissue engineering: the role of biomechanics. J Biomech Eng 2000, 122(6):570-575.
116. Sacks M.S., Schoen F.J., Mayer J.E. Bioengineering challenges for heart valve tissue engineering. Annu Rev Biomed Eng 2009, 11:289-313.
117. Freed L.E., Guilak F., Guo X.E., Gray M.L., Tranquillo R., Holmes J.W., Radisic M., Sefton M.V., Kaplan D., Vunjak-Novakovic G. Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling. Tissue Eng 2006, 12(12):3285-3305.
118. Mironov V., Kasyanov V.A., Yost M.J., Visconti R., Twal W., Trusk T., Wen X., Ozolanta I., Kadishs A., Prestwich G.D., Terracio L., Markwald R.R. Cardiovascular tissue engineering I. Perfusion bioreactors: a review. J Long Term Eff Med Implants 2006, 16(2):111-130.
119. CryoLife Inc. News release: Cryolife Inc. receives " CE mark" approval for distribution of Synergraft tissue-engineered pulmonary heart valves in Europe. Atlanta, Ga: CryoLife Inc.; 2000.
120. Simon P., Kasimir M.T., Seebacher G., Weigel G., Ullrich R., Salzer-Muhar U., Rieder E., Wolner E. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 2003, 23:1002-1006.